What it is
Simvastatin is a lipophilic statin given as a prodrug and activated in the liver. Depending on the dose, it lowers LDL cholesterol by 25 to 40%. It is effective and cheap, but it is a very sensitive CYP3A4 substrate: anything that inhibits that enzyme sends its levels and the risk of myopathy soaring.
It is still used in primary and secondary prevention, although atorvastatin and rosuvastatin have displaced it when more potency is needed. Because of its short half-life, it is taken at night.
Mechanism of action
It inhibits:
- Its active form inhibits liver HMG-CoA reductase
- It lowers LDL by 25–40% depending on the dose
- It raises HDL moderately
At the counter
When to recommend it
- Hypercholesterolaemia with moderate cardiovascular risk
- Secondary prevention (after a heart attack or stroke), if tolerated and reaching the target
- Moderate dyslipidaemia
- Patients already doing well on it and reaching their LDL target
When not to
- Allergy to statins
- Active liver disease
- Strong CYP3A4 inhibitors (itraconazole, ketoconazole, clarithromycin, erythromycin, protease inhibitors), gemfibrozil or ciclosporin
- Pregnancy and breastfeeding
Warnings
- Important Myopathy: a higher risk than with atorvastatin, especially at high doses + CYP3A4 inhibitors.
- Important CYP3A4 interactions: many drugs send it soaring (azoles, macrolides, protease inhibitors, grapefruit juice). With amlodipine or amiodarone, do not exceed 20 mg of simvastatin.
- Caution Muscle aches: common and generally mild. They need to be told apart from myopathy.
- Caution Raised liver enzymes: monitor ALT/AST.
Pharmacokinetics
- Absorption
- Rapid oral absorption. Bioavailability of about 5% (intense first-pass metabolism).
- Distribution
- The active metabolite accumulates in the liver. Protein binding above 95%.
- Metabolism
- Extensive hepatic metabolism via CYP3A4: it is a very sensitive substrate, so inhibitors of that enzyme greatly increase its concentration.
- Elimination
- Biliary elimination. Half-life of 2–3 hours, although the active metabolites last longer.
Simvastatin vs atorvastatin
| Aspect | Simvastatin | Atorvastatin |
|---|---|---|
| LDL-lowering potency | Moderate (25–40%) | High (35–55%) |
| CYP3A4 interactions | Many (very sensitive substrate) | Moderate |
| Myopathy risk | Higher (especially with inhibitors) | Lower |
| Cost | Lower (cheap generic) | Higher |
| First line today | No (second line) | Yes |
Simvastatin if cost is decisive or the patient already tolerates it. Atorvastatin if more potency is needed or there are several medicines.
Self-assessment
Three questions. When you check your answers you will see the explanation for each one.
-
Simvastatin is a very sensitive CYP3A4 substrate: drugs that inhibit that enzyme send its levels and the risk of myopathy soaring.
-
Clarithromycin is a strong CYP3A4 inhibitor. With simvastatin it increases the risk of myopathy. It needs a medical decision.
-
Simvastatin is eliminated quickly and cholesterol synthesis is higher at night, so taking it at night makes better use of its effect. With atorvastatin, which has a long half-life, the time does not matter.
Training content. It does not replace the summary of product characteristics or clinical judgement.